Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Gardasil 9 vs Gardasil in Girls 9-15 Years Old
NCT01304498Phase 3Completed
- Sponsor
- Merck & Co.
- Start
- Feb 2011
- Primary completion
- Dec 2011
- Modality
- Vaccines & Immunotherapeutics
01
Overview
A Phase 3 trial of recombinant human papillomavirus 9-valent vaccine in human papillomavirus infection, sponsored by Merck & Co.. Started Feb 2011; status: completed.
02
Drugs
recombinant human papillomavirus 9-valent vaccine
03
Conditions
human papillomavirus infection
Beyond the preview
Go deeper on NCT01304498.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01304498.